NO20011276L - Oralt administrert kontrollert legemiddel-leveringssystem som tilveiebringer temporal og spatial kontroll - Google Patents

Oralt administrert kontrollert legemiddel-leveringssystem som tilveiebringer temporal og spatial kontroll

Info

Publication number
NO20011276L
NO20011276L NO20011276A NO20011276A NO20011276L NO 20011276 L NO20011276 L NO 20011276L NO 20011276 A NO20011276 A NO 20011276A NO 20011276 A NO20011276 A NO 20011276A NO 20011276 L NO20011276 L NO 20011276L
Authority
NO
Norway
Prior art keywords
delivery system
drug delivery
orally administered
system providing
controlled drug
Prior art date
Application number
NO20011276A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011276D0 (no
Inventor
Naresh Talwar
Himadri Sen
John H Staniforth
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/152,932 external-priority patent/US6261601B1/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of NO20011276D0 publication Critical patent/NO20011276D0/no
Publication of NO20011276L publication Critical patent/NO20011276L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20011276A 1998-09-14 2001-03-13 Oralt administrert kontrollert legemiddel-leveringssystem som tilveiebringer temporal og spatial kontroll NO20011276L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,932 US6261601B1 (en) 1997-09-19 1998-09-14 Orally administered controlled drug delivery system providing temporal and spatial control
PCT/IB1999/000078 WO2000015198A1 (en) 1998-09-14 1999-01-19 Orally administered controlled drug delivery system providing temporal and spatial control

Publications (2)

Publication Number Publication Date
NO20011276D0 NO20011276D0 (no) 2001-03-13
NO20011276L true NO20011276L (no) 2001-05-10

Family

ID=22545063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011276A NO20011276L (no) 1998-09-14 2001-03-13 Oralt administrert kontrollert legemiddel-leveringssystem som tilveiebringer temporal og spatial kontroll

Country Status (40)

Country Link
EP (2) EP1107741B1 (de)
JP (1) JP2002524494A (de)
CN (1) CN1186013C (de)
AP (1) AP1659A (de)
AR (1) AR022672A1 (de)
AT (1) ATE245414T1 (de)
AU (1) AU758324B2 (de)
BG (1) BG105339A (de)
BR (1) BR9913696A (de)
CA (1) CA2343760A1 (de)
CO (1) CO5130022A1 (de)
CU (1) CU23040A3 (de)
CZ (1) CZ2001901A3 (de)
DE (1) DE69909801T2 (de)
DK (1) DK1107741T3 (de)
EA (2) EA004443B1 (de)
EE (1) EE200100153A (de)
ES (1) ES2204098T3 (de)
GE (1) GEP20043216B (de)
HR (1) HRP20010187B1 (de)
HU (1) HUP0103632A3 (de)
ID (1) ID29843A (de)
IL (1) IL141977A0 (de)
IS (1) IS5885A (de)
MX (1) MXPA01002634A (de)
MY (1) MY127952A (de)
NO (1) NO20011276L (de)
NZ (2) NZ523747A (de)
OA (1) OA11652A (de)
PE (1) PE20001058A1 (de)
PL (1) PL346798A1 (de)
PT (1) PT1107741E (de)
SI (1) SI1107741T1 (de)
SK (1) SK285478B6 (de)
SV (1) SV1999000152A (de)
TR (1) TR200100731T2 (de)
UA (1) UA73287C2 (de)
UY (1) UY25710A1 (de)
WO (1) WO2000015198A1 (de)
ZA (1) ZA995839B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1263409A1 (de) * 2000-03-03 2002-12-11 Ranbaxy Laboratories, Limited Oral anzuwendendes system mit gesteuerter wirkstoffabgabe zur einmal täglichen verabreichung von ciprofloxacin
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
AU2006202275A1 (en) * 2000-06-26 2006-06-22 Bayer Healthcare Ag Sustained-release preparations of quinolone antibiotics and method for preparation thereof
AU2001276748A1 (en) * 2000-08-08 2002-02-18 Daiichi Pharmaceutical Co., Ltd. Highly absorbable solid preparation
IN192748B (de) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
AU2002221412B2 (en) * 2000-12-05 2006-04-13 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
BR0211317A (pt) * 2001-07-04 2004-12-14 Sun Pharmaceutical Ind Ltd Sistema para a liberação controlada de uma droga por meio de retenção gástrica
JP2005501097A (ja) * 2001-08-16 2005-01-13 ザ ステイト オブ オレゴン アクティング バイ アンド スルー ザ ステイト ボード オブ ハイアー エデュケイション、 オン ビハーフ オブ オレゴン ステイト ユニバーシティー 膨張可能な胃内滞留装置
US6673369B2 (en) * 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
CA2466032A1 (en) * 2001-10-29 2003-05-08 Laure Patricia Ouadji Njiki Methods and dosage forms for improving the bioavailability of therapeutic agents
JP4882200B2 (ja) * 2001-11-13 2012-02-22 アステラス製薬株式会社 水溶性薬物徐放化技術
US8192755B2 (en) 2001-11-19 2012-06-05 Lupin Limited Pharmaceutical composition for controlled release of a beta-lactam antibiotic
AU2002311622A1 (en) * 2002-04-23 2003-11-10 Lupin Limited Long acting compositions comprising zidovudine and lamivudine
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
RU2385724C2 (ru) * 2004-06-28 2010-04-10 Солвей Фармасьютикалс Б.В. Пероральная композиция тедисамила с замедленным высвобождением, обладающая свойством задержки в желудке
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
GB0501810D0 (en) * 2005-01-28 2005-03-09 Pharmakodex Ltd Chemotherapeutic formulations
RS20070512A (sr) * 2005-06-29 2009-01-22 Panacea Biotec Ltd., Farmaceutske kompozicije sa zadržanim otpuštanjem i postupci za njihovo dobijanje
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
ZA200903854B (en) * 2008-06-19 2011-02-23 Univ Of The Witwatesrand Johannesburg A gastroretentive pharmaceutical dosage form
KR20110042366A (ko) 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
WO2011125075A2 (en) 2010-04-08 2011-10-13 Fdc Limited A novel gastroretentive delivery of macrolide
EP2415460A1 (de) * 2010-08-03 2012-02-08 ratiopharm GmbH Orale Darreichungsform von Pregabalin
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
CN106999429B (zh) 2014-11-19 2020-09-18 杜邦营养美国有限公司 纳米悬浮剂制剂
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
WO2018232413A1 (en) 2017-06-16 2018-12-20 Kashiv Pharma Llc Gastroretentive dosage forms for sustained drug delivery
DK3609472T3 (da) 2018-06-18 2021-04-06 Kashiv Specialty Pharmaceuticals Llc Forlænget frigivelsessammensætning indeholdende pyridostigmin
JP7034343B2 (ja) 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
CN110448535A (zh) * 2019-09-04 2019-11-15 湖南宇山玉月农业科技有限公司 一种裂褶菌素胃漂浮片
CN111116794A (zh) * 2019-12-20 2020-05-08 蚌埠市鑫晟新材料科技有限公司 一种中性造纸用聚合材料的制备方法
CN115715765A (zh) * 2021-08-24 2023-02-28 江苏万邦生化医药集团有限责任公司 一种悬浮片剂
CN113768898A (zh) * 2021-09-14 2021-12-10 江苏万邦生化医药集团有限责任公司 悬浮的胶囊片

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798742B2 (ja) * 1986-07-03 1995-10-25 ゼリア新薬工業株式会社 徐放性製剤組成物
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤

Also Published As

Publication number Publication date
ES2204098T3 (es) 2004-04-16
IL141977A0 (en) 2002-03-10
CN1186013C (zh) 2005-01-26
HRP20010187B1 (en) 2004-04-30
EE200100153A (et) 2002-06-17
NZ523747A (en) 2004-04-30
SK285478B6 (sk) 2007-02-01
OA11652A (en) 2004-12-08
EA004443B1 (ru) 2004-04-29
ID29843A (id) 2001-10-18
AR022672A1 (es) 2002-09-04
SK3472001A3 (en) 2001-10-08
CZ2001901A3 (cs) 2001-08-15
BG105339A (en) 2001-11-30
EA200300847A1 (ru) 2003-12-25
BR9913696A (pt) 2001-10-09
GEP20043216B (en) 2004-04-26
HUP0103632A2 (hu) 2002-02-28
TR200100731T2 (tr) 2001-06-21
PE20001058A1 (es) 2000-10-05
AP2001002098A0 (en) 2001-03-31
DE69909801T2 (de) 2004-06-03
IS5885A (is) 2001-03-12
DE69909801D1 (de) 2003-08-28
UA73287C2 (en) 2005-07-15
ZA995839B (en) 2000-03-28
AP1659A (en) 2006-09-06
CN1325299A (zh) 2001-12-05
UY25710A1 (es) 2000-03-31
CU23040A3 (es) 2005-04-14
ATE245414T1 (de) 2003-08-15
AU758324B2 (en) 2003-03-20
EP1107741A1 (de) 2001-06-20
CO5130022A1 (es) 2002-02-27
DK1107741T3 (da) 2003-11-17
HRP20010187A2 (en) 2002-04-30
HUP0103632A3 (en) 2005-06-28
WO2000015198A1 (en) 2000-03-23
SI1107741T1 (en) 2004-02-29
EA005767B1 (ru) 2005-06-30
EP1281397A1 (de) 2003-02-05
NZ510487A (en) 2003-04-29
MY127952A (en) 2007-01-31
AU1779499A (en) 2000-04-03
CA2343760A1 (en) 2000-03-23
JP2002524494A (ja) 2002-08-06
MXPA01002634A (es) 2002-06-04
NO20011276D0 (no) 2001-03-13
HK1037967A1 (en) 2002-03-01
PT1107741E (pt) 2003-12-31
EP1107741B1 (de) 2003-07-23
SV1999000152A (es) 2000-07-03
EA200100346A1 (ru) 2001-10-22
PL346798A1 (en) 2002-02-25

Similar Documents

Publication Publication Date Title
NO20011276D0 (no) Oralt administrert kontrollert legemiddel-leveringssystem som tilveiebringer temporal og spatial kontroll
EE9800025A (et) Transkorneaalne süsteem ravimite manustamiseks
ATE209497T1 (de) Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
NO994837L (no) Intravesikal medikamentavleveringssystem
ATA903696A (de) Elektrotransport-medikamentenverabreichung
NO20016277D0 (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske formuleringer
PT1051217E (pt) Sistema de controlo osmotico de administracao de medicamento
EP1091732A4 (de) Arzneistoffverabreichungssystem mit brauseaktivität zur oralen verabreichung
AU6271401A (en) Drug administering system and administering method
NO20014035D0 (no) System for oral administrasjon av medikament
ID28232A (id) Formulasi farmasi dengan pelepasan terkontrol
PL342515A1 (en) Drug administering device
IL159875A0 (en) Zero order controlled drug delivery system
EP1061987A4 (de) Vorrichtung zum verabreichen eines medikamentes
FI961437A7 (fi) Vaikuttavan aineen luovuttava systeemi
IL211081A0 (en) Methods and devices for providing prolonged drug therapy
EP1013269A4 (de) Verbesserung eines systems zur verabreichung von medikamenten
NO20002526D0 (no) Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav
GB9815723D0 (en) Drug administration and ordering systems
GB9503322D0 (en) Medicament administration dummy
DK1183061T3 (da) Lægemiddelafgivelsessystem
KR960028327U (ko) 가축용 분말 약제 투여장치
IT1304899B1 (it) Metodo e dispositivo per la somministrazione di farmaci
GB9816436D0 (en) Multiple therapy drug delivery
GB9800835D0 (en) Drug delivery system